Nuvexa Biologic
Innovative Biotech Solution
At Nuvexa Biologix, we are committed to advancing regenerative wellness through the power of exosome science. Our mission is to provide cutting-edge, high-quality biologic products that support healing, recovery, and overall functional wellness for patients and providers alike.
We specialize exclusively in premium exosome-based formulations, offering innovative solutions for clinics, wellness centers, and aesthetic providers looking to enhance their outcomes with trusted biologic therapies. All of our products are manufactured in FDA-registered facilities under strict quality control standards and are backed by third-party sterility and safety testing.
With a focus on education, transparency, and ongoing support, we partner with licensed professionals to deliver real results—safely and effectively. Whether used for recovery, rejuvenation, or performance optimization, Nuvexa stands at the forefront of the regenerative biologics space.
Solutions We Offer
NUVEXA 50
Approved for Cosmetic, Research,
& Homologous Use
Nuvexa 50 is a high-potency, lyophilized exosome formulation designed to deliver elevated regenerative and anti-inflammatory performance with full transparency and clinical flexibility. Each sterile vial contains 50 billion mesenchymal stem cell (MSC)–derived exosomes sourced from Wharton’s Jelly—significantly surpassing the typical market standard of fewer than 10 billion exosomes per dose. Developed through extensive research and refinement, Nuvexa 50 leverages umbilical cord–derived exosomes rich in placental, vascular endothelial, and transforming growth factors to support cellular communication, tissue repair, and immune modulation. Its acellular, lyophilized format preserves biologic integrity without refrigeration, allows for convenient reconstitution with normal saline, and supports versatile delivery via IV or nebulization, making Nuvexa 50 a shelf-stable, ready-to-use solution engineered for practitioners seeking potency, purity, and application versatility.
NUVEXA 90
Approved for Cosmetic, Research,
& Homologous Use
Nuvexa 90 is a high-performance, lyophilized exosome formulation engineered to set a new benchmark in regenerative potency and clinical versatility. Delivering an industry-leading 90 billion cord blood–derived exosomes per vial—far exceeding typical market concentrations—Nuvexa 90 is the result of extensive research and precision manufacturing. Derived from umbilical cord blood and enriched with placental, vascular endothelial, and transforming growth factors, this acellular formulation supports robust regenerative signaling while offering exceptional flexibility for systemic and IV infusion applications. Utilizing an advanced lyophilization process to preserve peptides, proteins, and growth factors without refrigeration, and packaged in clear glass vials with fully disclosed contents, Nuvexa 90 embodies transparency, purity, and convenience—empowering practitioners with a research-grade exosome solution designed to deliver consistently elevated outcomes.
NUVEXA 100
Approved for Cosmetic, Research
, & Homologous Use
Nuvexa 100 is a scientifically validated, cord blood (plasma)–derived exosome formulation engineered to deliver exceptional purity, potency, and regenerative signaling. Derived from human progenitor endothelial stem cells (hPESCs) and supported by published peer-reviewed research, Nuvexa 100 is rigorously characterized using ELISA, nanoparticle tracking analysis, and advanced particle imaging to ensure biologic activity and consistency. The formulation contains membrane-enclosed exosomes expressing CD81 and CD9 and delivers a robust profile of regenerative and anti-inflammatory factors—including IGFBPs, insulin, growth hormone, PDGF-AA, TGF-β1, VEGF, and IL-1RA—shown to promote fibroblast proliferation and stem cell migration, making it a comprehensive, evidence-backed solution for advanced regenerative applications.
NUVEXA 180
Approved for Cosmetic, Research
, & Homologous Use
NUVEXA 180 is a next-generation, cord blood (plasma)–derived exosome formulation delivering an industry-leading 180 billion exosomes per vial, designed for clinicians who demand maximum potency, scientific validation, and absolute transparency. Derived from human progenitor endothelial stem cells (hPESCs) and supported by published, peer-reviewed research on both process and efficacy, Nuvexa 180 is rigorously characterized using ELISA, nanoparticle tracking analysis, and advanced single-particle imaging to confirm biologic activity and consistency. The formulation contains membrane-enclosed exosomes expressing CD81 and CD9 and delivers a comprehensive regenerative signaling profile—including IGFBP 1, 2, 3, and 6, insulin, growth hormone, PDGF-AA, TGF-β1, VEGF, and the anti-inflammatory cytokine IL-1RA—shown to promote fibroblast proliferation and stem cell migration. Cryo-frozen via an advanced dehydration process to preserve peptides, proteins, and growth factors, and packaged in clear glass vials with fully disclosed contents, Nuvexa 180 stands apart as a high-yield, research-grade exosome solution with unmatched pedigree and documented proof.
NUVEXA 30
(Topical Use Only)
Approved for Cosmetic, Research, & Homologous Use
Nuvexa 30 is a targeted, lyophilized exosome formulation engineered specifically for advanced skin regeneration, post-procedure recovery, and aesthetic optimization. Each sterile vial delivers 30 billion umbilical cord–derived exosomes enriched with essential peptides and growth factors that stimulate elastin and collagen production while helping reduce post-treatment redness and visible inflammation. Developed through extensive research, Nuvexa 30 harnesses placental, vascular endothelial, and transforming growth factor signaling to accelerate healing from cosmetic procedures and protect skin from daily environmental and sun-related stressors. Its shelf-stable, lyophilized format preserves biologic activity without refrigeration, offering a convenient, high-potency solution designed to support consistent skin rejuvenation and enhanced aesthetic outcomes.
NUVEXA PRP
70MG 3ML
Nuvexa PRP redefines regenerative injectable therapy by offering a Wharton’s Jelly–derived, collagen-based mesenchymal connective tissue that delivers the benefits of PRP without the pain, inflammation, or operational complexity. Sourced from the extracellular matrix of umbilical cord Wharton’s Jelly, Nuvexa PRP provides an exceptionally high concentration of mesenchymal signaling components per milliliter, enriched with collagen, hyaluronic acid, chondroitin sulfate, and proteoglycans to support tissue repair, structural integrity, and accelerated healing. This acellular, immune-privileged formulation eliminates the need for centrifugation, allows for virtually painless application with fine-gauge needles, and significantly reduces inflammatory responses commonly associated with traditional PRP—while delivering superior consistency, cost efficiency, and regenerative outcomes for both practitioners and patients.
NUVEXA JELLY 300MG 2ML
NNuvexa Jelly is a next-generation regenerative biologic derived from umbilical cord Wharton’s Jelly, engineered to deliver consistent, pain-free, and highly predictable healing outcomes. Formulated from the extracellular matrix of Wharton’s Jelly, it provides a collagen-based mesenchymal connective tissue rich in regenerative components—including collagen, hyaluronic acid, chondroitin sulfate, proteoglycans, elastin, and fibronectin—that support tissue repair, structural integrity, and cellular adhesion. Unlike traditional PRP, which is often associated with inflammation, discomfort, and variability, Nuvexa Jelly is acellular, immune privileged, and anti-inflammatory, allowing for smooth administration with fine-gauge needles and improved patient tolerance. Designed as a modern alternative to PRP, Nuvexa Jelly combines biological precision with regenerative performance to support advanced therapeutic and aesthetic applications with greater efficiency and reliability.
NUVEXA JELLY 150MG 1ML
Nuvexa Jelly is a next-generation regenerative biologic derived from the pure extracellular matrix of umbilical cord Wharton’s Jelly, engineered to deliver powerful, predictable healing without the pain, inflammation, or cost associated with traditional PRP. This collagen-based mesenchymal connective tissue provides one of the highest concentrations of regenerative components per milliliter, including collagen, hyaluronic acid, chondroitin sulfate, proteoglycans, elastin, and fibronectin—supporting structural repair, anti-inflammatory signaling, and tissue rejuvenation. Immune privileged and designed for painless administration with fine-gauge needles, Nuvexa Jelly offers a safe, cost-efficient, and clinically practical alternative for facial, joint, scalp, and regenerative applications, empowering practitioners with consistent outcomes and elevated patient experience.
NUVEXA FLOW
2ML
Nuvexa Flow is an advanced, umbilical cord–derived growth factor matrix engineered to deliver next-generation regenerative support through exceptional purity and biologic concentration. Formulated using Advanced Ultra Filtration, Nuvexa Flow provides a tissue-free, debris-free growth factor media containing 80 million mesenchymal growth factors designed to support cellular repair, immunomodulation, and tissue rejuvenation. This biologically rich matrix delivers collagenic growth factors, proteoglycans, regulatory proteins, cytokines, and peptides, with a favorable signaling profile that includes IL-1, IL-4, IL-10, TGF-β2, VEGF, and PGF. Backed by peer-reviewed research on Wharton’s Jelly–derived factors, Nuvexa Flow offers a clean, potent, and easy-to-use solution for practitioners seeking consistent, whole-body regenerative performance.
NUVEXA FLOW
1ML
Nuvexa Flow is a next-generation, umbilical cord–derived growth factor formulation engineered to deliver concentrated regenerative signaling with exceptional purity and clinical versatility. Each vial contains 40 million mesenchymal growth factors, produced through advanced ultra-filtration technology to create a tissue-free, debris-free media that preserves the biologic integrity of Wharton’s Jelly–derived components. Rich in collagenic growth factors, proteoglycans, cytokines, and peptides, Nuvexa Flow is designed to support cellular repair, tissue regeneration, and overall rejuvenation. Supported by peer-reviewed research and optimized for systemic, localized, or IV-administered applications, Nuvexa Flow provides practitioners with a clean, potent, and reliable solution for elevating regenerative outcomes.
Who we serve
Reclaim Health partners with physician-led practices seeking compliant, high-quality regenerative solutions without the burden of sourcing, vetting, or integration complexity.
Regenerative & longevity clinics
Integrative and functional medicine practices
Medical spas (MD/DO owned)
Specialty practices expanding into peptides
How it Works
How It Works – Biologics Ordering & Support Getting started with our biologics is simple and streamlined. Begin by contacting one of our consultants, who will guide you through the setup process and coordinate the creation of a direct account with the appropriate laboratory partner. Once your account is established, you will receive secure, online access to the lab’s ordering portal, allowing you to place orders directly, efficiently, and on demand.
Our team remains available throughout the process to provide ongoing support, answer questions, and assist with product selection, protocols, and logistics—ensuring a smooth, compliant, and hassle-free experience from onboarding to delivery.
COMPLIANCE & CLINICAL RESPONSIBILITY
All products and services are:
Provided to licensed medical professionals
Prescribed, dispensed, and managed at the physician’s discretion
Intended to support clinical decision-making, not replace it
Reclaim Health does not practice medicine and does not provide direct patient treatment.
TESTIMONIALS
What Are Our Customers Saying ?
"As a physician with over 20 years of experience, I’ve never seen such transformative results until I began using the regenerative products and systems provided by this team. The quality of the biologics — from exosomes to stem cells — is unmatched, and the integration of advanced equipment like red light therapy and PEMF has taken my patient outcomes to another level. What sets them apart is not just the products, but the support behind them. From clinical training to business strategy, they’ve helped streamline my practice and elevate the care I provide. This isn’t the future of medicine — it’s happening now."
Small Call to Action Headline
DR. Drucker
